• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多杀性巴氏杆菌 PlpE 蛋白表位的计算机分析作为新型亚单位疫苗候选物。

In silico Analysis of Pasteurella multocida PlpE Protein Epitopes As Novel Subunit Vaccine Candidates.

机构信息

Molecular Biology Department, Pasteur Institute of Iran, Tehran, Iran.

Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.

出版信息

Iran Biomed J. 2021 Jan;25(1):41-6. doi: 10.29252/ibj.25.1.41. Epub 2020 Jan 4.

DOI:10.29252/ibj.25.1.41
PMID:33129238
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7748120/
Abstract

BACKGROUND

Pasteurella multocida is a Gram-negative, non-motile, non-spore forming, and aerobic/anaerobic cocobacillus known as the causative agent of human and animal diseases. Humans can often be affected by cat scratch or bite, which may lead to soft tissue infections and in rare cases to bacteremia and septicemia. Commercial vaccines against this agent include inactivated, live attenuated, and non-pathogenic bacteria. Current vaccines have certain disadvantages such as reactogenicity or reversion to virulence. Therefore, the aim of this study was to reach a multi-epitope vaccine candidate that could be serotype independent and covers most incident serotypes of P. multocida.

METHODS

In this study, reverse vaccinology strategy was used to identify potentially immunogenic and protective epitopes. First, multiple alignments of different sequences of Pasteurella lipoprotein E (PlpE) from various serotypes of P. multocida were analyzed to identify the conserved regions. Bioinformatics tools were then applied to predict and select epitopes for further studies.

RESULTS

Three different conserved immunogenic regions were selected according to the selected criteria, and their various sequential orders were evaluated structurally by in silico tools to find the best order.

CONCLUSION

In searching the epitopes of PlpE to design a new vaccine candidate against pasteurellosis, we found the region 1 + region 2 + region 3 (without any linker between regions) of epitope, including the regions of PlpE protein of P. multocida, as the appropriate serotype independent vaccine candidate against pasteurellosis.

摘要

背景

多杀巴斯德菌是一种革兰氏阴性、非运动性、非孢子形成、需氧/厌氧球杆菌,是人类和动物疾病的病原体。人类通常会因猫抓伤或咬伤而感染,这可能导致软组织感染,极少数情况下还会导致菌血症和败血症。针对该病原体的商业疫苗包括灭活疫苗、减毒活疫苗和非致病性细菌。目前的疫苗存在一定的缺点,如反应原性或回复毒力。因此,本研究的目的是开发一种多表位疫苗候选物,该候选物可以与血清型无关,并涵盖大多数多杀巴斯德菌的偶发血清型。

方法

在这项研究中,反向疫苗学策略被用于鉴定潜在的免疫原性和保护性表位。首先,对来自不同多杀巴斯德菌血清型的脂蛋白 E(PlpE)的多个序列进行多重比对,以鉴定保守区域。然后应用生物信息学工具来预测和选择表位进行进一步研究。

结果

根据选定的标准选择了三个不同的保守免疫原性区域,并通过计算工具评估了它们的各种顺序结构,以找到最佳的顺序。

结论

在搜索 PlpE 的表位以设计针对巴氏杆菌病的新型疫苗候选物时,我们发现包括多杀巴斯德菌 PlpE 蛋白区域在内的表位的区域 1+区域 2+区域 3(区域之间没有任何连接子),是针对巴氏杆菌病的合适的与血清型无关的疫苗候选物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d65b/7748120/cf8592158282/ibj-25-41-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d65b/7748120/6e5ef98d8e20/ibj-25-41-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d65b/7748120/cfbbe14f4828/ibj-25-41-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d65b/7748120/cf8592158282/ibj-25-41-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d65b/7748120/6e5ef98d8e20/ibj-25-41-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d65b/7748120/cfbbe14f4828/ibj-25-41-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d65b/7748120/cf8592158282/ibj-25-41-g003.jpg

相似文献

1
In silico Analysis of Pasteurella multocida PlpE Protein Epitopes As Novel Subunit Vaccine Candidates.多杀性巴氏杆菌 PlpE 蛋白表位的计算机分析作为新型亚单位疫苗候选物。
Iran Biomed J. 2021 Jan;25(1):41-6. doi: 10.29252/ibj.25.1.41. Epub 2020 Jan 4.
2
PlpE Protein Polytope as a Potential Subunit Vaccine Candidate.髓鞘蛋白脂蛋白E(PlpE)蛋白多表位作为潜在的亚单位疫苗候选物。
Vector Borne Zoonotic Dis. 2021 Nov;21(11):870-874. doi: 10.1089/vbz.2020.2758.
3
Protective immunity conferred by recombinant Pasteurella multocida lipoprotein E (PlpE).重组多杀性巴氏杆菌脂蛋白E(PlpE)赋予的保护性免疫
Vaccine. 2007 May 22;25(21):4140-8. doi: 10.1016/j.vaccine.2007.03.005. Epub 2007 Mar 20.
4
Immunogenicity and protective efficacy of the recombinant Pasteurella lipoprotein E and outer membrane protein H from Pasteurella multocida A:3 in mice.多杀性巴氏杆菌 A:3 重组脂蛋白 E 和外膜蛋白 H 对小鼠的免疫原性和保护效力。
Res Vet Sci. 2012 Dec;93(3):1261-5. doi: 10.1016/j.rvsc.2012.05.011. Epub 2012 Jun 20.
5
Immunogenicity and protective efficacy of the recombinant lipoproteins VacJ and PlpE, and outer membrane protein H from P. multocida A:1 in ducks.多杀性巴氏杆菌 A:1 型重组脂蛋白 VacJ 和 PlpE 及外膜蛋白 H 的免疫原性和保护效力在鸭子中的研究。
Front Immunol. 2022 Oct 7;13:985993. doi: 10.3389/fimmu.2022.985993. eCollection 2022.
6
Combinations but Not a Single PlpE Epitope Induces Host Protective Immunity against Pasteurella multocida.组合而非单一 PlpE 表位诱导宿主对多杀性巴氏杆菌产生保护性免疫。
Infect Immun. 2023 Mar 15;91(3):e0027222. doi: 10.1128/iai.00272-22. Epub 2023 Feb 23.
7
Recombinant-attenuated Salmonella enterica serovar Choleraesuis vector expressing the PlpE protein of Pasteurella multocida protects mice from lethal challenge.表达多杀性巴氏杆菌 PlpE 蛋白的重组减毒猪霍乱沙门氏菌载体可保护小鼠免受致死性攻击。
BMC Vet Res. 2023 Aug 19;19(1):128. doi: 10.1186/s12917-023-03679-0.
8
Immune responses against chimeric DNA and protein vaccines composed of plpEN-OmpH and PlpEC-OmpH from Pasteurella multocida A:3 in mice.小鼠针对多杀性巴氏杆菌A:3的plpEN-OmpH和PlpEC-OmpH组成的嵌合DNA和蛋白质疫苗的免疫反应。
Acta Microbiol Immunol Hung. 2012 Dec;59(4):485-98. doi: 10.1556/AMicr.59.2012.4.6.
9
In-silico analysis of Pasteurella multocida to identify common epitopes between fowl, goat and buffalo.多杀性巴氏杆菌的计算机模拟分析,以确定家禽、山羊和水牛之间的共同表位。
Gene. 2016 Apr 10;580(1):58-66. doi: 10.1016/j.gene.2016.01.020. Epub 2016 Jan 15.
10
Immunogenicity of highly conserved recombinant VacJ outer membrane lipoprotein of Pasteurella multocida.多杀性巴氏杆菌高度保守重组 VacJ 外膜脂蛋白的免疫原性。
Vaccine. 2014 Jan 3;32(2):290-6. doi: 10.1016/j.vaccine.2013.10.075. Epub 2013 Nov 23.

引用本文的文献

1
Genomic characterization and comparative genomic analysis of HS-associated Pasteurella multocida serotype B:2 strains from Pakistan.巴基斯坦 HSPA 相关多杀性巴氏杆菌血清型 B:2 菌株的基因组特征和比较基因组分析。
BMC Genomics. 2023 Sep 14;24(1):546. doi: 10.1186/s12864-023-09626-5.
2
Global commercialization and research of veterinary vaccines against : 2015-2022 technological surveillance.2015 - 2022年全球兽用疫苗商业化与研究:技术监测
Vet World. 2023 May;16(5):946-956. doi: 10.14202/vetworld.2023.946-956. Epub 2023 May 9.
3
Immunogenicity and protective efficacy of the recombinant lipoproteins VacJ and PlpE, and outer membrane protein H from P. multocida A:1 in ducks.

本文引用的文献

1
Vaccine Candidates: A Systematic Review.候选疫苗:一项系统综述。
Avicenna J Med Biotechnol. 2020 Jul-Sep;12(3):140-147.
2
Protective efficacy afforded by live Pasteurella multocida vaccines in chickens is independent of lipopolysaccharide outer core structure.鸡用多杀性巴氏杆菌活疫苗提供的保护效力与脂多糖外核结构无关。
Vaccine. 2016 Mar 29;34(14):1696-703. doi: 10.1016/j.vaccine.2016.02.017. Epub 2016 Feb 16.
3
Non-zoonotic Pasteurella multocida Infection as a Cause of Septic Shock in a Patient with Liver Cirrhosis: A Case Report and Review of the Literature.
多杀性巴氏杆菌 A:1 型重组脂蛋白 VacJ 和 PlpE 及外膜蛋白 H 的免疫原性和保护效力在鸭子中的研究。
Front Immunol. 2022 Oct 7;13:985993. doi: 10.3389/fimmu.2022.985993. eCollection 2022.
4
Spatial, Temporal, and Demographic Patterns in the Prevalence of Hemorrhagic Septicemia in 41 Countries in 2005-2019: A Systematic Analysis with Special Focus on the Potential Development of a New-Generation Vaccine.2005 - 2019年41个国家出血性败血症患病率的空间、时间和人口模式:一项特别关注新一代疫苗潜在研发的系统分析
Vaccines (Basel). 2022 Feb 17;10(2):315. doi: 10.3390/vaccines10020315.
5
The immune response and protective efficacy of a potential DNA vaccine against virulent Pasteurella multocida.一种潜在的抗强毒多杀性巴氏杆菌DNA疫苗的免疫反应及保护效力
J Genet Eng Biotechnol. 2021 May 31;19(1):81. doi: 10.1186/s43141-021-00180-9.
非人畜共患多杀巴斯德菌感染作为肝硬化患者感染性休克的病因:病例报告及文献复习
J Glob Infect Dis. 2013 Oct;5(4):176-8. doi: 10.4103/0974-777X.122016.
4
Development of immunization trials against Pasteurella multocida.多杀性巴氏杆菌免疫试验的研制。
Vaccine. 2014 Feb 12;32(8):909-17. doi: 10.1016/j.vaccine.2013.11.068. Epub 2013 Dec 2.
5
Immune responses and protective efficacy of a novel DNA vaccine encoding outer membrane protein of avian Pasteurella multocida.一种编码禽多杀性巴氏杆菌外膜蛋白的新型DNA疫苗的免疫应答及保护效力
Vet Immunol Immunopathol. 2013 Apr 15;152(3-4):317-24. doi: 10.1016/j.vetimm.2013.01.001. Epub 2013 Jan 8.
6
Screening of 71 P. multocida proteins for protective efficacy in a fowl cholera infection model and characterization of the protective antigen PlpE.在禽霍乱感染模型中筛选 71 种多杀性巴氏杆菌蛋白以评估其保护效力,并鉴定保护性抗原 PlpE。
PLoS One. 2012;7(7):e39973. doi: 10.1371/journal.pone.0039973. Epub 2012 Jul 5.
7
Immunogenicity and protective efficacy of the recombinant Pasteurella lipoprotein E and outer membrane protein H from Pasteurella multocida A:3 in mice.多杀性巴氏杆菌 A:3 重组脂蛋白 E 和外膜蛋白 H 对小鼠的免疫原性和保护效力。
Res Vet Sci. 2012 Dec;93(3):1261-5. doi: 10.1016/j.rvsc.2012.05.011. Epub 2012 Jun 20.
8
Veterinary vaccines and their use in developing countries.兽用疫苗及其在发展中国家的应用。
Rev Sci Tech. 2007 Apr;26(1):179-201.
9
Protective immunity conferred by recombinant Pasteurella multocida lipoprotein E (PlpE).重组多杀性巴氏杆菌脂蛋白E(PlpE)赋予的保护性免疫
Vaccine. 2007 May 22;25(21):4140-8. doi: 10.1016/j.vaccine.2007.03.005. Epub 2007 Mar 20.
10
Immunogenicity and efficacy of three recombinant subunit Pasteurella multocida toxin vaccines against progressive atrophic rhinitis in pigs.三种重组亚单位多杀性巴氏杆菌毒素疫苗对猪进行性萎缩性鼻炎的免疫原性和效力
Vaccine. 2006 Jan 9;24(1):27-35. doi: 10.1016/j.vaccine.2005.07.079. Epub 2005 Aug 9.